Tengchuang Ma

3PUBLICATIONS
2CO-AUTHORS
Haematological tumoursRadiation therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 14, 2026
Disrupting fumarylacetoacetate hydrolase by stratified nanoplatforms orchestrates metabolic-immune reprogramming and prevents post-ablation HCC relapse.

|Oct 16, 2025
Gadd45B Deficiency Drives Radio-Resistance in BRAFV600E-Mutated Differentiated Thyroid Cancer by Disrupting Iodine Metabolic Genes.

Shan Jiang, Zhiwen Hong, Qianjiang Wu

|Apr 23, 2025
Drug Delivery Platform Targeting MMP9 in Combination with Photothermal Therapy to Improve Tumor Chemosensitivity.

Jixian Fu, Chunyu Song, Shan Jiang

Pageof 1

Frequent Collaborators

1 joint publications

Ari A Kassardjian

1 joint publications

Zhiwen Hong